Abstract WP172: Significance of sleep impairment after acute ischemic stroke: results of the OPTIMISTmain study

Le résumé fourni par la source

Background: Sleep impairment is common in patients after acute ischemic stroke (AIS) but few studies have examined the associated predictor variables and prognostic significance. Aims: To determine the factors associated with sleep impairment in patients with mild to moderate AIS who participated in the main Optimal Post rTpa-IV Monitoring in Ischemic Stroke Trial (OPTIMISTmain). Methods: OPTIMISTmain was an international, multicenter, stepped wedge, cluster randomized non-inferiority controlled trial with blinded outcome assessment, that aimed to determine the safety and effectiveness of low-intensity versus standard monitoring in stable thrombolysis-treated AIS patients. Sleep-related impairment was assessed at 7 days with an eight-item short-form questionnaire referred to as The Patient-Reported Outcome Measurement Information System (PROMIS). The primary outcome was unfavorable functional recovery (mRS 2-6) at 90 days. Secondary outcomes include death; death or dependency (mRS 3-6) and EQ-5D-5L visual analogue scale score. Total raw scores were converted to T-score , where >50 (mean for US general population) indicated sleep-related impairment. Analysis used logistic or linear regression models with adjustment for study design and potential confounders (P<0.2 in univariate analysis). Results: Of 4922 OPTIMISTmain participants, 3078 (62.5%) completed the PROMIS scale for a valid T-score (mean 46.1, SD 9.4), and 1242 (40.3%) had sleep impairment. Patients with sleep impairment were more likely female, non-Asian, and smokers, with a history of heart disease or hypercholesterolemia, and a greater neurological impairment (Table 1). From multivariable analysis (Table 2), female (p=0.0052), non-Asian (0.0042), and stroke severity on NIHSS (<0.0001) were independently associated with sleep impairment. Sleep impairment was associated with unfavorable functional recovery (adjusted odds ratio [aOR] 2.18, 95% CI 1.80-2.65, p<0.0001; Table 3), death or dependency (aOR 2.72, 95% CI 2.11-3.50, p<0.0001) and worse health quality of life (adjusted mean difference -5.35, 95% CI-6.58 to -4.12, p<0.0001). Conclusions: Sleep impairment is associated with poor outcomes in thrombolysis-treated patients with mild-to-moderate AIS. Sex, ethnicity and stroke severity were independently associated with sleep impairment after AIS.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.